H-NS mutation-mediated CRISPR-cas activation inhibits phage release and toxin production of Escherichia coli Stx2 phage lysogen

13Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

Abstract

Shiga toxin-converting bacteriophages (Stx phages) carry the stx gene and convert nonpathogenic bacterial strains into Shiga toxin-producing bacteria. There is limited understanding of the effect that an Escherichia coli (E. coli) clustered regularly interspaced short palindromic repeats (CRISPR)-Cas adaptive immune system has on Stx phage lysogen. We investigated heat-stable nucleoid-structuring (H-NS) mutation-mediated CRISPR-Cas activation and its effect on E. coli Stx2 phage lysogen. The Δhns mutant (MG1655Δhns) of the E. coli K-12 strain MG1655 was obtained. The Δhns mutant lysogen that was generated after Stx phage lysogenic infection had a repressed growth status and showed subdued group behavior, including biofilm formation and swarming motility, in comparison to the wild-type strain. The de-repression effect of the H-NS mutation on CRISPR-Cas activity was then verified. The results showed that cas gene expression was upregulated and the transformation efficiency of the wild-type CRISPR plasmids was decreased, which may indicate activation of the CRISPR-Cas system. Furthermore, the function of CRISPR-Cas on Stx2 phage lysogen was investigated by activating the CRISPR-Cas system, which contains an insertion of the protospacer regions of the Stx2 phage Min27. The phage release and toxin production of four lysogens harboring the engineered CRISPRs were investigated. Notably, in the supernatant of the Δhns mutant lysogen harboring the Min27 spacer, both the progeny phage release and the toxin production were inhibited after mitomycin C induction. These observations demonstrate that the H-NS mutation-activated CRISPR-Cas system plays a role in modifying the effects of the Stx2 phage lysogen. Our findings indicated that H-NS mutation-mediated CRISPR-Cas activation in E. coli protects bacteria against Stx2 phage lysogeny by inhibiting the phage release and toxin production of the lysogen.

References Powered by Scopus

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

12306Citations
N/AReaders
Get full text

The CRISPR/cas bacterial immune system cleaves bacteriophage and plasmid DNA

1859Citations
N/AReaders
Get full text

Bacteriophage resistance mechanisms

1756Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Recent advances in CRISPR-based systems for the detection of foodborne pathogens

35Citations
N/AReaders
Get full text

Bacteriophage Transcription Factor Cro Regulates Virulence Gene Expression in Enterohemorrhagic Escherichia coli

34Citations
N/AReaders
Get full text

Deconstructing the Phage–Bacterial Biofilm Interaction as a Basis to Establish New Antibiofilm Strategies

24Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fu, Q., Li, S., Wang, Z., Shan, W., Ma, J., Cheng, Y., … Sun, J. (2017). H-NS mutation-mediated CRISPR-cas activation inhibits phage release and toxin production of Escherichia coli Stx2 phage lysogen. Frontiers in Microbiology, 8(APR). https://doi.org/10.3389/fmicb.2017.00652

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

63%

Professor / Associate Prof. 6

25%

Researcher 2

8%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 15

48%

Agricultural and Biological Sciences 13

42%

Medicine and Dentistry 2

6%

Engineering 1

3%

Save time finding and organizing research with Mendeley

Sign up for free